申请人:SYNTEX (U.S.A.) INC.
公开号:EP0061333A1
公开(公告)日:1982-09-29
Compounds useful in the prevention and/or treatment of hypertension, congestive heart failure, arrhythmia, migraine, vasospastic disorders, and asthma are represented by the formula
wherein:
R, R1, R2, R3, and R4 are independently hydrogen or lower alkyl of one to four carbon atoms; and
R5 and R6 are independently hydrogen, lower alkyl of one to four carbon atoms or lower alkoxy of one to four carbon atoms; and
the pharmaceutically acceptable acid addition salts thereof.
用于预防和/或治疗高血压、充血性心力衰竭、心律失常、偏头痛、血管痉挛性疾病和哮喘的化合物由式表示
其中
R、R1、R2、R3 和 R4 独立地为氢或一至四个碳原子的低级烷基;以及
R5 和 R6 独立地是氢、一至四个碳原子的低级烷基或一至四个碳原子的低级烷氧基;以及
其药学上可接受的酸加成盐。